Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 27247217)

Published in J Clin Oncol on May 31, 2016

Authors

Simer J Bains1, Milada Mahic1, Tor Åge Myklebust1, Milada Cvancarova Småstuen1, Sheraz Yaqub1, Liv Marit Dørum1, Bjørn Atle Bjørnbeth1, Bjørn Møller1, Kristoffer Watten Brudvik1, Kjetil Taskén2

Author Affiliations

1: Simer J. Bains, Kjetil Taskén, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo; Milada Mahic, Norwegian Institute of Public Health; Tor Åge Myklebust, Liv Marit Dørum, Bjørn Møller, Cancer Registry of Norway; and Simer J. Bains, Milada Cvancarova Småstuen, Sheraz Yaqub, Bjørn Atle Bjørnbeth, Kristoffer Watten Brudvik, Kjetil Taskén, Oslo University Hospital, Oslo, Norway.
2: Simer J. Bains, Kjetil Taskén, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo; Milada Mahic, Norwegian Institute of Public Health; Tor Åge Myklebust, Liv Marit Dørum, Bjørn Møller, Cancer Registry of Norway; and Simer J. Bains, Milada Cvancarova Småstuen, Sheraz Yaqub, Bjørn Atle Bjørnbeth, Kristoffer Watten Brudvik, Kjetil Taskén, Oslo University Hospital, Oslo, Norway kjetil.tasken@ncmm.uio.no.